Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?
Laurila Sanna; Rebelos Eleni; Honka Miikka-Juhani; Nuutila Pirjo
Pleiotropic Effects of Secretin: A Potential Drug Candidate in the Treatment of Obesity?
Laurila Sanna
Rebelos Eleni
Honka Miikka-Juhani
Nuutila Pirjo
Frontiers in Endocrinology
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021102752680
https://urn.fi/URN:NBN:fi-fe2021102752680
Tiivistelmä
Secretin is the first hormone that has been discovered, inaugurating the era and the field of endocrinology. Despite the initial focus, the interest in its actions faded away over the decades. However, there is mounting evidence regarding the pleiotropic beneficial effects of secretin on whole-body homeostasis. In this review, we discuss the evidence from preclinical and clinical studies based on which secretin may have a role in the treatment of obesity.
Kokoelmat
- Rinnakkaistallenteet [27094]